What are the side effects of veozah?

What side effects do people report most often?

Veozah (fezolinetant) is a non-hormonal drug approved for moderate to severe hot flashes caused by menopause. The most common side effects reported in clinical trials are diarrhea, insomnia, and abdominal pain. These occurred at rates higher than placebo. Some women also experienced back pain and hot flushes themselves.

How serious are the rare but serious side effects?

Rare but serious side effects include liver injury. The FDA requires a boxed warning because some patients developed elevated liver enzymes that could lead to severe liver damage. Liver function must be monitored before treatment and at one month, three months, and six months after start. If liver tests show violations of certain thresholds, Veozah must be stopped.

What happens if liver tests show problems?

If liver tests show problems, the drug must be stopped immediately. Patients are advised to watch for signs of liver injury such as new or worsening fatigue, nausea, vomiting, yellowing of skin or eyes, or dark urine. These signs require immediate medical attention.

When does Veozah’s patent expire?

Veozah’s patent expires in 2035.